SIGA Technologies, Inc.

SIGA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.21-1.83%

2026-08-03

Financials

Valuation Metrics

SIGA Technologies, Inc.'s Market Cap is $230M. At end of 2025 it was $438M. Ranked #3016 of 3,112 in US market (top 97%), #1368 of 1,445 on NASDAQ (top 95%), #251 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 93%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$230M	US#3,016/3,112 Sec#251/269
Revenue	$94M	US#2,795/3,112 Sec#128/269
Net Income	$20M	US#2,069/3,112 Sec#69/269
Total Assets	$219M	US#2,964/3,112 Sec#245/269
Net Assets	$152M	US#2,805/3,112 Sec#213/269
Value
P/E	11.36x	US#336/3,112 Sec#14/269
P/B	1.52x	US#836/3,112 Sec#37/269
P/S	2.46x	US#1,491/3,112 Sec#41/269
EV/EBITDA	3.10x	US#56/3,112 Sec#7/269
FCF Yield	11.91%	US#370/3,112 Sec#14/269
Profitability
ROE	13.36%	US#990/3,112 Sec#49/269
ROA	9.24%	US#508/3,112 Sec#36/269
Op. Margin	22.00%	US#800/3,112 Sec#37/269
Revenue Growth	-11.34%	US#2,690/3,112 Sec#149/269
Earnings Growth	-60.65%	US#1,913/3,112 Sec#57/269
Financial Health
Debt Ratio	44.69%	US#512/3,112 Sec#136/269
Total Debt	$638231.00	US#2,944/3,112 Sec#253/269
FCF	$27M	US#2,092/3,112 Sec#74/269
Cash	$146M	US#1,949/3,112 Sec#146/269
Current Ratio	3.25x	US#732/3,112 Sec#186/269
Net Debt/EBITDA	-5.27x	US#63/3,112 Sec#3/269
Dividend
Div. Yield	0.11%	US#1,676/3,112 Sec#26/269
Div. Growth	1.06%	US#1,131/3,112 Sec#20/269
Performance
1Y Return	-50.31%	US#2,989/3,112 Sec#249/269
1M Return	-16.84%	US#2,878/3,112 Sec#219/269
From 52W High	-66.63%	US#2,995/3,112 Sec#249/269
1Y MDD	-67.30%	US#2,874/3,112 Sec#241/269
Trading
Volume	514,279 shares	US#2,050/3,112 Sec#200/269
Trading Value	$2M	US#2,960/3,112 Sec#249/269
Per Share
EPS	$0.33	US#1,919/3,112 Sec#64/269
BPS	$2776645.40	US#2/3,112 Sec#1/269